Stephen Baxter
Stock Analyst at Wells Fargo
(3.31)
# 2,462
Out of 5,182 analysts
261
Total ratings
48.19%
Success rate
2.26%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MOH Molina Healthcare | Maintains: Equal-Weight | $141 → $159 | $186.35 | -14.68% | 24 | Apr 27, 2026 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $481 → $436 | $437.37 | -0.31% | 20 | Apr 27, 2026 | |
| UNH UnitedHealth Group | Maintains: Overweight | $370 → $397 | $362.64 | +9.47% | 17 | Apr 22, 2026 | |
| HUM Humana | Maintains: Equal-Weight | $206 → $227 | $228.97 | -0.86% | 15 | Apr 7, 2026 | |
| CON Concentra Group Holdings Parent | Maintains: Overweight | $25 → $28 | $22.88 | +22.38% | 1 | Mar 5, 2026 | |
| UHS Universal Health Services | Maintains: Equal-Weight | $235 → $212 | $168.55 | +25.78% | 18 | Mar 2, 2026 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $43 → $50 | $47.83 | +4.54% | 9 | Mar 2, 2026 | |
| AGL agilon health | Maintains: Overweight | $25 → $38 | $27.09 | +38.43% | 11 | Feb 27, 2026 | |
| MDLN Medline | Maintains: Equal-Weight | $42 → $47 | $44.51 | +5.59% | 2 | Feb 27, 2026 | |
| CNC Centene | Maintains: Equal-Weight | $43 → $44 | $46.43 | -5.23% | 26 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $405 → $429 | $311.65 | +37.65% | 6 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $237 → $256 | $204.08 | +25.44% | 11 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $914 → $925 | $832.33 | +11.13% | 10 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $424 → $391 | $362.56 | +7.84% | 16 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $38 | $30.89 | +23.02% | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $252 → $229 | $181.12 | +26.44% | 17 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3 → $2 | $2.86 | -29.95% | 12 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $14 → $11 | $17.48 | -37.07% | 13 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $102 | $81.00 | +25.93% | 16 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $354 → $300 | $288.36 | +4.04% | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $5.88 | +155.10% | 3 | Apr 29, 2024 |
Molina Healthcare
Apr 27, 2026
Maintains: Equal-Weight
Price Target: $141 → $159
Current: $186.35
Upside: -14.68%
HCA Healthcare
Apr 27, 2026
Maintains: Equal-Weight
Price Target: $481 → $436
Current: $437.37
Upside: -0.31%
UnitedHealth Group
Apr 22, 2026
Maintains: Overweight
Price Target: $370 → $397
Current: $362.64
Upside: +9.47%
Humana
Apr 7, 2026
Maintains: Equal-Weight
Price Target: $206 → $227
Current: $228.97
Upside: -0.86%
Concentra Group Holdings Parent
Mar 5, 2026
Maintains: Overweight
Price Target: $25 → $28
Current: $22.88
Upside: +22.38%
Universal Health Services
Mar 2, 2026
Maintains: Equal-Weight
Price Target: $235 → $212
Current: $168.55
Upside: +25.78%
BrightSpring Health Services
Mar 2, 2026
Maintains: Overweight
Price Target: $43 → $50
Current: $47.83
Upside: +4.54%
agilon health
Feb 27, 2026
Maintains: Overweight
Price Target: $25 → $38
Current: $27.09
Upside: +38.43%
Medline
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $42 → $47
Current: $44.51
Upside: +5.59%
Centene
Feb 18, 2026
Maintains: Equal-Weight
Price Target: $43 → $44
Current: $46.43
Upside: -5.23%
Feb 10, 2026
Maintains: Overweight
Price Target: $405 → $429
Current: $311.65
Upside: +37.65%
Feb 10, 2026
Maintains: Overweight
Price Target: $237 → $256
Current: $204.08
Upside: +25.44%
Feb 5, 2026
Maintains: Equal-Weight
Price Target: $914 → $925
Current: $832.33
Upside: +11.13%
Jan 30, 2026
Maintains: Overweight
Price Target: $424 → $391
Current: $362.56
Upside: +7.84%
Jan 7, 2026
Maintains: Overweight
Price Target: $31 → $38
Current: $30.89
Upside: +23.02%
Jan 7, 2026
Maintains: Overweight
Price Target: $252 → $229
Current: $181.12
Upside: +26.44%
Jan 7, 2026
Maintains: Underweight
Price Target: $3 → $2
Current: $2.86
Upside: -29.95%
Nov 13, 2025
Maintains: Underweight
Price Target: $14 → $11
Current: $17.48
Upside: -37.07%
Nov 13, 2025
Maintains: Overweight
Price Target: $103 → $102
Current: $81.00
Upside: +25.93%
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $354 → $300
Current: $288.36
Upside: +4.04%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $5.88
Upside: +155.10%